Expert Interview
Evaluating the potential of Nektar's Rezpegaldesleukin (IL-2 inhibitor) in patients with Alopecia Areata
Ticker(s): NKTRInstitution: Harvard Medical School
Associate Professor of Dermatology at Harvard Medical School and Vice Chair of Clinical Trials and Innovation at Brigham and Women’s Hospital
Currently manages over 150 patients with alopecia areata.
Reseaarch focus on alopecia areata, complex medical dermatology, diagnostic testing, and health disparities.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
